The abortion president, Barack Obama, has made use of his last months in office to give yet another gift to the abortion industry, a leading pro-life Congressman said today.
“Today, Obama’s Food and Drug Administration (FDA) changed the label of the abortion pill (mifepristone) to enable the expanded use of this baby-killing drug,” said U.S. Rep. Chris Smith (NJ-04), Co-Chair of the Bipartisan Congressional Pro-life Caucus. “At the behest of the abortion industry, the Obama Administration has extended the use of the drug to 10 weeks of pregnancy. Additionally the new label eliminates the follow-up visit to the physician prior to taking the second part of the drug protocol, and expands who may administer this dangerous drug.”
Smith said, “Not only is mifepristone used to kill babies, it is a poison that has harmed and even killed women. Yet even with this record, in the last months of his term, President Obama has bowed to pressure from his abortion cronies and has further expanded the use of the abortion pill, putting the health and lives of even more women and children at risk.
Click here to sign up for pro-life news alerts from LifeNews.com
“Abortion advocates today are celebrating FDA’s expansion of ‘medication abortion,’ but women who have suffered the trauma of a mifepristone abortion know that it is not ‘medication’– this chemical poison is not designed to heal, or cure, or mitigate pain,” said Smith.
Smith pointed to the controversial origins of the original approval of mifepristone in the United States. At the beginning of the Clinton administration, Clinton issued an Executive Order instructing the FDA to re-evaluate the status of RU-486. FDA Commissioner Kessler even urged the European patent-holder, Roussel Uclaf, to submit an application for approval of what was then called RU-486. When mainstream drug manufacturers refused to bring this baby-killing drug to the United States, Population Council licensed the drug and abortion proponents created DANCO for one purpose and one purpose only, to distribute mifepristone in the United States. Headquartered in the Cayman Islands, DANCO had the abortion drug manufactured in China and packaged in New Jersey.
After a campaign that began at the start of the Clinton Administration, Smith recalled that the abortion pill was first pushed through the FDA approval process under intense political pressure during the final days of the Administration, in a desperate attempt to get the drug approved before the 2000 elections. The drug was given a pass and expedited for political gain at the expense of women’s health and lives.
